Increased vial size of Blockbuster drug Keytruda drives billions of waste

Daniel Goldstein, et. al.

Journal of the National Cancer Institute, 07/21/2021

VIVIO clinical team member, Daniel Goldstein is referenced in Peter Bach’s scathing commentary in Health Affairs on the waste being driven by vial size games played by Pharma. The original article describes how Merck’s increase of vial size has led to billions of dollars of Keytruda being thrown away.

Visit W3Schools